Details for New Drug Application (NDA): 008915
✉ Email this page to a colleague
NDA 008915 describes CLISTIN, which is a drug marketed by Mcneil and Ortho Mcneil Pharm and is included in two NDAs. Additional details are available on the CLISTIN profile page.
The generic ingredient in CLISTIN is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
The generic ingredient in CLISTIN is carbinoxamine maleate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the carbinoxamine maleate profile page.
Summary for 008915
| Tradename: | CLISTIN |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | carbinoxamine maleate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
